IMMUTEP Ltd
IMMP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001506184
No open-market purchases or sales by IMMUTEP Ltd insiders were filed in the last 90 days; 25 institutions reported holding it in 13F filings for Q2 2026, worth $692.0K in total; no superinvestor holds it.
Other share classesPRRUF
13F holders, Q1 2025
Institutional positions in IMMUTEP Ltd as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 23
- −3 vs. Q4 2024
- Shares held
- 1.68M
- −264.7K (−13.6%) vs. Q4 2024
- Total value
- $2.95M
- −$1.27M (−30.1%) vs. Q4 2024
- New holders
- 2
- 6 more added
- Sold out
- 5
- 9 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IMMP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 25 | $692.0K |
| Q1 2026 | 26 | $916.3K |
| Q4 2025 | 25 | $5.68M |
| Q3 2025 | 32 | $3.68M |
| Q2 2025 | 24 | $2.75M |
| Q1 2025 | 23 | $2.95M |
| Q4 2024 | 26 | $4.22M |
| Q3 2024 | 23 | $4.26M |
| Q2 2024 | 28 | $4.84M |
| Q1 2024 | 23 | $5.40M |
| Q4 2023 | 23 | $4.90M |
| Q3 2023 | 21 | $3.68M |
| Q2 2023 | 21 | $3.41M |
| Q1 2023 | 19 | $4.95M |
| Q4 2022 | 25 | $7.25M |
| Q3 2022 | 21 | $8.31M |
| Q2 2022 | 22 | $11.2M |
| Q1 2022 | 23 | $14.4M |
| Q4 2021 | 25 | $17.5M |
| Q3 2021 | 28 | $30.9M |
| Q2 2021 | 28 | $32.9M |
| Q1 2021 | 13 | $14.0M |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding IMMUTEP Ltd; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 648,312 | $1.14M | 0.00% | −92,101−12.4% | Reduced |
| Meridian Wealth Management, LLC | 386,650 | $680.5K | 0.03% | −7,500−1.9% | Reduced |
| XY Capital Ltd | 136,744 | $240.7K | 0.16% | −27,911−17.0% | Reduced |
| Steward Partners Investment Advisory, LLC | 61,000 | $107.4K | 0.00% | +61,000 | New |
| Jane Street Group, LLC | 51,574 | $90.8K | 0.00% | +6,617+14.7% | Added |
| Susquehanna International Group, LLP | 47,457 | $83.5K | 0.00% | −68,662−59.1% | Reduced |
| Dimensional Fund Advisors LP | 45,489 | $80.1K | 0.00% | 00.0% | Unchanged |
| Marex Group plc | 38,000 | $66.9K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 37,038 | $65.2K | 0.00% | +35,584+2,447.3% | Added |
| Verition Fund Management LLC | 35,000 | $61.6K | 0.00% | 00.0% | Unchanged |
| LPL Financial LLC | 34,612 | $60.9K | 0.00% | +80+0.2% | Added |
| Rhumbline Advisers | 27,449 | $48.3K | 0.00% | −1,278−4.4% | Reduced |
| Tower Research Capital LLC (TRC) | 25,104 | $44.2K | 0.00% | +19,487+346.9% | Added |
| UBS Group AG | 24,008 | $42.3K | 0.00% | +989+4.3% | Added |
| Geode Capital Management, LLC | 18,722 | $33.0K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 15,405 | $27.1K | 0.00% | −962−5.9% | Reduced |
| Fortitude Advisory Group L.L.C. | 18,300 | $26.5K | 0.02% | +5,400+41.9% | Added |
| Morgan Stanley | 14,276 | $25.1K | 0.00% | −15,313−51.8% | Reduced |
| XTX Topco Ltd | 11,071 | $19.5K | 0.00% | +11,071 | New |
| Bank of America Corp | 2,220 | $3.91K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 16 | $28 | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 51 | $0 | 0.00% | −10,251−99.5% | Reduced |
| Royal Bank of Canada | 197 | $0 | 0.00% | −4,750−96.0% | Reduced |
| Abc Arbitrage SA | 0 | $0 | 0.00% | −69,897−100.0% | Sold out |
| PFG Investments, LLC | 0 | $0 | 0.00% | −51,000−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −34,025−100.0% | Sold out |
| Old Mission Capital LLC | 0 | $0 | 0.00% | −16,791−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −4,500−100.0% | Sold out |